27
BIOVENTRIX, INC. files Form D
Company raise update · Raising · Offering $10M · Sold $3M · MANSFIELD, MA · filed 2026-09-09
Bioventrix, a Delaware biotechnology corporation based in Mansfield, MA, is raising $3M under Regulation D exemption 6(b). The company has sold $1.2M to six investors so far with a $50K minimum and $1.8M remaining in the offering.
| Steven Chartier | Executive Officer, Director |
| Dave Richmond | Executive Officer, Director |
| Rishi Puri | Director |
| Mark Ravich | Director |
| William Abraham | Director |
Signed by Molly Claire Benjamin, Account Administrator.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.